<DOC>
	<DOCNO>NCT00401531</DOCNO>
	<brief_summary>The purpose study provide immunogenicity safety data investigational hexavalent vaccine give concomitantly ( day separate injection site ) Prevnar , accord 2-4-6 month immunization schedule , follow one dose HB vaccine birth . Primary Objective : To demonstrate hexavalent DTaP-IPV-HB-PRP~T combine vaccine induces immune response least good response follow Infanrix™-Hexa term seroprotection rate HB PRP , one month 3 dose primary series ( 2 , 4 , 6 month ) , co-administered Prevnar® Secondary Objectives : Immunogenicity : To describe group immunogenicity parameter vaccine component ( DTaP-IPV-HB-PRP~T Infanrix™-Hexa ) one month third dose primary series . Safety : To describe overall safety injection .</brief_summary>
	<brief_title>Comparison DTaP-IPV-HB-PRP~T Combined Vaccine Infanrix™-Hexa , When Administered With Prevnar® Thai Infants</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion Criteria : Two month old infant ( 50 71 day old ) day inclusion , either gender . Born full term pregnancy ( &gt; = 37 week ) birth weight &gt; = 2.5 kg . Hepatitis B vaccination since birth . Informed consent form sign one parent/legally acceptable representative independent witness parent/legally acceptable representative illiterate . Able attend schedule visit comply trial procedure . Exclusion Criteria : Participation another clinical trial 4 week precede first trial vaccination . Planned participation another clinical trial present trial period . Systemic hypersensitivity vaccine component history life threaten reaction trial vaccine vaccine contain substance . Congenital acquire immunodeficiency , immunosuppressive therapy longterm systemic corticosteroid therapy . Chronic illness stage could interfere trial conduct completion . Blood bloodderived product receive since birth . Any vaccination 4 week precede first trial vaccination . Any planned vaccination ( except trial vaccination ) trial . Documented history pertussis , T , D , polio , Hib , hepatitis B Streptococcus pneumoniae infection ( ) ( confirm either clinically , serologically , microbiologically ) . Previous vaccination pertussis , tetanus , diphtheria , poliomyelitis , Haemophilus influenzae type b infection ( ) Streptococcus pneumoniae . Known personal maternal history HIV , HB ( HbsAg carrier ) hepatitis C seropositivity . Known thrombocytopenia bleed disorder contraindicate IM vaccination . History seizure . Febrile ( rectal equivalent temperature &gt; = 38.0°C ) acute illness day inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>50 Days</minimum_age>
	<maximum_age>71 Days</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Polio</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>Pertussis</keyword>
	<keyword>H. influenzae type b</keyword>
</DOC>